MicroRNAs as Biomarkers for Parkinson's Disease
Myers, R. H., et at., MicroRNAs as Biomarkers for Parkinson's Disease. Poster session presented at: International Congress of Parkinson's Disease and Movement Disorders. 2018 Oct 5-9; Hong Kong.
Categories
Filter by Topics
AACR2023 ALK aplastic anemia AA Autoimmune Disorder B-cell lymphoma Biology of neoplasia Biomarkers Bladder Cancer bone Brain Breast Cancer CD3 Cells Cerebrospinal Fluid clinical trial cold tumor Colorectal cancer Comparison study CXCL12 Cytokines Developmental Immunotherapy Developmental Therapeutics Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug sensitivity EHE cancer Encephalophy EPCORE NHL-1 ERBB3 FFPE Gene Expression Profiling Genetic Polymorphism Heart Histone Deacetylase Inhibitors hot tumor HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System HTP Immune Checkpoint Inhibitors Immune Response Immune-related Colitis Immuno-Oncology IMMUNOSARC Immunotherapy IOA- 244 IRP Kidney Liposarcoma liver Liver Lung lungs Lymphoma lymphoma Melanoma melanoma Microenvironment miRNA miRNA WTA Molecular Characterization Nash and Fibrosis Natural Killer Cells Nestin+ Neurologic non-Hodgkin Lymphoma Non-Hodgkin lymphoma NHL OBP Oesophageal Adenocarcinoma Oral cancer oral squamous cell carcinoma OSCC PanB Pancreas pancreatic ductal adenocarcinoma PDAC Parkinson's Disease Pathway Analysis PDX model PI3K inhibitors PIP Plasma Platform Comparison Programmed cell death protein 1 Prostate qNPA qPCR Radioimmunotherapy Rheumatoid Arthritis Sarcoma Serum Signatures soft tissue sarcoma Sub-typing Survival plots T cells Thymic Carcinoma Tislelizumab TME Transplantation Treatment Outcome Treatment Targets Tumor Biology Tumor Immunobiology Tumor infiltrating lymphocytes Zanubrutinlb2018
Empowering rare disease cohort biomarker discovery via comparative assessments of gene expression analysis platforms for FFPE pediatric brain tumor specimens.
Koptyra, M., et al. Empowering rare disease cohort biomarker discovery via comparative assessments of gene expression analysis platforms for FFPE pediatric brain tumor specimens. Abstract #2081 presented at: American Association for Cancer Research Annual Meeting (AACR) 2018 Apr 14-18; Chicago, IL
Download pdf 6.3MB
View External Link
2017
HTG EdgeSeq miRNA Whole Transcriptome Assay Platform Performance Metrics Utilizing the MicroRNA (miRQC) Study Specimens
Aissaoui S., HTGEdgeSeq miRNA Whole Transcriptome Assay Platform Performance Metrics Utilizing the MicroRNA (miRQC) Study Specimens. Poster presented at: The European Human Genetics Conference (ESHG). 2017 May; Copenhagen, Denmark.
- Categories
- Posters
Validation of our HTG EdgeSeq Platform for accurate and sensitive biomarker discovery
Danilin S., et al. Validation of our HTG EdgeSeq Platform for accurate and sensitive biomarker discovery. Poster session presented at Molecular Diagnostics Europe. 2017 Apr; Lisbon, Portugal
- Categories
- Posters
Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating miRNAs for Diagnosis of Nash and Fibrosis
Francque, S. et. al, Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating miRNAs for Diagnosis of Nash and Fibrosis. Poster session presented at: The International Liver Congress (ILC), 2017 Apr; Amsterdam
- Categories
- Posters
Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating mirNAs for Diagnosis of Nash and Fibrosis
Francque S., et al. Next-Generation Sequencing (NGS) of Two Independent Cohorts Identifies Eleven Circulating mirNAs for Diagnosis of Nash and Fibrosis. Poster session presented at: The International Liver Congress (ILC), 2017 Apr; Amsterdam
- Categories
- Posters
2016
Verification of miRNA Expression using Nuclease Protection and Targeted Next-Generation Sequencing (NGS)
Reinholz M., et al. Verification of miRNA Expression using Nuclease Protection and Targeted Next-Generation Sequencing (NGS). Poster session presented at: The European Society of Human Genetics; 2016; Barcelona, Spain.
Combining Automated Tissue Dissection with Extraction Free Nucleic Acid Analysis
Lo B., et al. Combining Automated Tissue Dissection with Extraction Free Nucleic Acid Analysis. J Mol Diag. 2016, 18: 1048.
2015
Reproducibility and Bias of miRNA Profiling with the HTG EdgeSeq Targeted Capture and Sequencing Assay
Barczak A.J., et al. Reproducibility and Bias of miRNA Profiling with the HTG EdgeSeq Targeted Capture and Sequencing Assay. Poster session presented at: The External RNA Control Consortium (ERCC) 2015 meeting.
2014
Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing
Thompson D., et al. Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing. Poster session presented at: 64th annual meeting of the American Society of Human Genetics; 2014 October 18-22; San Diego, CA
Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing
Thompson D., et al. Automated high fidelity miRNA expression profiling using nuclease protection coupled with next generation sequencing. Poster session presented at: Merck Technology Symposium; 2014 May; Long Branch, NJ.
- Categories
- Posters
Non-small cell lung cancer histological sub-typing by gene expression analysis from FFPE tissue.
Wang E., et al. Non-small cell lung cancer histological sub-typing by gene expression analysis from FFPE tissue. Cancer Res. 2014;74(19 Suppl):abstr 1877.
Download pdf 2.2MB
View External Link
Page last updated May 22, 2023